Fluctuating Encephalopathy With Bulbar Dysfunction and Sleep‐Disordered Breathing: A Diagnostic Challenge Highlighting a Treatable Autoimmune Mimic of Neurodegenerative Disease

Anti‐IgLON5 disease is a rare neurological disorder with overlapping autoimmune and neurodegenerative features, often leading to delayed diagnosis due to phenotypic heterogeneity. Early identification of immune‐dominant cases is crucial, as they may respond to immunotherapy. We report a 67‐year‐old male presenting with progressive bulbar dysfunction, sleep‐disordered breathing, and intermittent hypercapnic respiratory failure over 6 months. Structural neuroimaging and cerebrospinal fluid analysis were unremarkable. FDG‐PET brain imaging suggested a neurodegenerative pattern; however, preserved dopaminergic uptake on 18F‐DOPA PET did not support a significant presynaptic nigrostriatal dopaminergic deficit. Polysomnography confirmed severe obstructive sleep apnea with nocturnal hypoventilation. Serum anti‐IgLON5 antibodies were very strongly positive on a tissue‐based assay using indirect immunofluorescence at a 1:10 dilution and were subsequently confirmed by a cell‐based assay. CSF anti‐IgLON5 antibody testing was not performed. Serum neurofilament light polypeptide was measured by sandwich enzyme‐linked immunosorbent assay (ELISA) and was reported as “not detected”; the laboratory did not provide a numerical lower limit of detection. The patient was treated with intravenous methylprednisolone, intravenous immunoglobulin, and rituximab, resulting in clinically meaningful improvement. This case highlights the importance of recognizing immune‐dominant anti‐IgLON5 disease. Multimodal imaging and biomarkers can differentiate it from neurodegenerative disorders, enabling early immunotherapy and improved outcomes.

Authors

Institutions

Publication Details

Journal
Neurology and Clinical Neuroscience
Published
2026-11-18
DOI
https://doi.org/10.1002/ncn3.70176
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fluctuating Encephalopathy With Bulbar Dysfunction and Sleep‐Disordered Breathing: A Diagnostic Challenge Highlighting a Treatable Autoimmune Mimic of Neurodegenerative Disease

Manjusha Yadav, Ashish Anand Susvirkar, Rachana Dhirubhai Patel, Haresh Shah et al.
2 links
Neurology and Clinical Neuroscience
Autoimmune Neurological Disorders and Treatments
article

Fluctuating Encephalopathy With Bulbar Dysfunction and Sleep‐Disordered Breathing: A Diagnostic Challenge Highlighting a Treatable Autoimmune Mimic of Neurodegenerative Disease

Manjusha Yadav, Ashish Anand Susvirkar, Rachana Dhirubhai Patel, Haresh Shah, Bhavita B Patel, Avani Jain
article en

Abstract

Anti‐IgLON5 disease is a rare neurological disorder with overlapping autoimmune and neurodegenerative features, often leading to delayed diagnosis due to phenotypic heterogeneity. Early identification of immune‐dominant cases is crucial, as they may respond to immunotherapy. We report a 67‐year‐old male presenting with progressive bulbar dysfunction, sleep‐disordered breathing, and intermittent hypercapnic respiratory failure over 6 months. Structural neuroimaging and cerebrospinal fluid analysis were unremarkable. FDG‐PET brain imaging suggested a neurodegenerative pattern; however, preserved dopaminergic uptake on 18F‐DOPA PET did not support a significant presynaptic nigrostriatal dopaminergic deficit. Polysomnography confirmed severe obstructive sleep apnea with nocturnal hypoventilation. Serum anti‐IgLON5 antibodies were very strongly positive on a tissue‐based assay using indirect immunofluorescence at a 1:10 dilution and were subsequently confirmed by a cell‐based assay. CSF anti‐IgLON5 antibody testing was not performed. Serum neurofilament light polypeptide was measured by sandwich enzyme‐linked immunosorbent assay (ELISA) and was reported as “not detected”; the laboratory did not provide a numerical lower limit of detection. The patient was treated with intravenous methylprednisolone, intravenous immunoglobulin, and rituximab, resulting in clinically meaningful improvement. This case highlights the importance of recognizing immune‐dominant anti‐IgLON5 disease. Multimodal imaging and biomarkers can differentiate it from neurodegenerative disorders, enabling early immunotherapy and improved outcomes.

Neurology and Clinical Neuroscience
Suamandeep Vidyapeeth University (IN), Bhailal Amin General Hospital (IN)
Good health and well-being
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon